Gynecologic Cancer News

Rates of early-stage cervical cancer decreased as rates of distant-stage disease increased among certain women in the U.S. between 2001 and 2018, according to study results.

Researchers at New York University, Weill Cornell Medicine and New York Genome Center have developed and tested a two-step approach that uses whole-exome sequencing to find genes and pathways that predict response to immunotherapy.

Women who take aspirin frequently may reduce their risk for ovarian cancer, according to results of a meta-analysis published in Journal of Clinical Oncology.

The University of Texas MD Anderson Cancer Center has retained its distinction as the No. 1 cancer hospital in the country.

A phase 3 trial of ofranergene obadenovec in platinum-resistant ovarian cancer failed to meet its primary endpoints of statistically significant improvement in PFS and OS, according to topline data released by the agent’s manufacturer.

Oncology clinical trials appeared to recover from declines in enrollment and activation during the early phase of the COVID-19 pandemic, according to a study of data from two large academic centers published in Annals of Oncology.

Our daily interactions with people energetically change how we feel about ourselves and our own circumstances.

The development of targeted cancer therapies has led to improved clinical outcomes for many patients. However, monotherapies against a single target can result in treatment resistance.

Widespread reductions in cancer screenings during the COVID-19 pandemic may be associated with delayed cancer diagnoses and increased mortality for breast, cervical and colon cancers, according to study results published in JAMA Oncology.

The COVID-19 pandemic disrupted treatment for gynecologic cancer patients worldwide and caused disease progression and death, according to a prospective cohort study in American Journal of Obstetrics & Gynecology.